La Jolla Pharmaceutical Co

FDA Filings

This page includes the latest FDA filings for La Jolla Pharmaceutical Co. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USANASDAQLJPCDUNS 613541192
FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
La Jolla Pharmaceutical Company, Cangene Biopharma, LLC dba Emergent BioSolutions
Prescription Medication2023-01-12
La Jolla Pharmaceutical Company
Giapreza2022-09-15
La Jolla Pharmaceutical Company, Cangene Biopharma, LLC dba Emergent BioSolutions
Prescription Medication2022-09-15
La Jolla Pharmaceutical Company, Cangene Biopharma, LLC dba Emergent BioSolutions
Prescription Medication2020-06-22
La Jolla Pharmaceutical Company, Cangene Biopharma, LLC dba Emergent BioSolutions
Prescription Medication2020-06-17
La Jolla Pharmaceutical Company, Cangene Biopharma, LLC dba Emergent BioSolutions
Prescription Medication2019-12-31
La Jolla Pharmaceutical Company, Cangene Biopharma, LLC dba Emergent BioSolutions
Prescription Medication2018-08-01
La Jolla Pharmaceutical Company
Giapreza2018-02-05

Similar & Related FDA Registered Companies

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.